Soleno Therapeutics Inc (SLNO) — Cash Flow Reinvestment Rate
Soleno Therapeutics Inc (SLNO) has a Cash Flow Reinvestment Rate of 0.00x as of March 2026, reinvesting $40.00K (capex $40.00K ) from operating cash flow of $25.98 Million. Check Soleno Therapeutics Inc (SLNO) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Soleno Therapeutics Inc Cash Flow Reinvestment Rate (2025–2025)
Historical reinvestment intensity for Soleno Therapeutics Inc across 1 annual periods. Explore SLNO strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Soleno Therapeutics Inc (2025–2025)
Year-by-year capital reinvestment analysis for Soleno Therapeutics Inc. For live market cap and broader valuation context, see market value of Soleno Therapeutics Inc.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 4.31x | $201.78 Million | $46.80 Million | $73.00K | — |